CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Phase Ia study of Atezolizumab (NCT01375842) monotherapy in relapsed endometrial cancer were reported as abstract at ASCO 2017. Fif...
Phase 3
Berlin, Berlin, Germany and 92 other locations
This is a multicenter, open-label, nonrandomized, Phase 2 umbrella study of retifanlimab in participants who have advanced or metastatic endometrial...
Phase 2
Berlin, Germany and 65 other locations
for maintenance selinexor in participants with advanced or recurrent endometrial cancer. Participants with primary stage IV or recu...
Phase 3
Berlin, Germany and 77 other locations
choice (doxorubicin or paclitaxel) for the treatment of advanced endometrial cancer. Participants will be randomly assigned to rece...
Phase 3
Berlin, Germany and 168 other locations
TROPION-PanTumor03 will investigate the safety, tolerability, and anti-tumour activity of Datopotamab Deruxtecan (Dato-DXd) as Monotherapy and in Com...
Phase 2
Berlin, Germany and 92 other locations
This study will test the safety of a drug called SGN-B7H4V in participants with solid tumors. It will also study the side effects of this dr...
Phase 1
Berlin, Other, Germany and 18 other locations
The purpose of this study is to evaluate the efficacy and safety of selinexor as a maintenance treatment in patients with p53 wt endometrial...
Phase 3
Berlin, Germany and 165 other locations
This study is designed to assess the efficacy and safety of ifinatamab deruxtecan (I-DXD) in the following tumor types: endometrial ...
Phase 2
Berlin, Germany and 105 other locations
cells (CAR-T) with or without CLDN6 ribonucleic acid lipoplexes (RNA-LPX) in patients with CLDN6-positive relapsed or refractory advanced solid tumors...
Phase 1
Berlin, Germany and 11 other locations
progression-free survival in participants with cervical cancer....
Phase 2
Berlin, Germany and 72 other locations
Clinical trials
Research sites
Resources
Legal